Does TARLATAMAB Cause Off label use? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Off label use have been filed in association with TARLATAMAB. This represents 9.7% of all adverse event reports for TARLATAMAB.
14
Reports of Off label use with TARLATAMAB
9.7%
of all TARLATAMAB reports
2
Deaths
6
Hospitalizations
How Dangerous Is Off label use From TARLATAMAB?
Of the 14 reports, 2 (14.3%) resulted in death, 6 (42.9%) required hospitalization, and 1 (7.1%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TARLATAMAB. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does TARLATAMAB Cause?
Cytokine release syndrome (59)
Death (31)
Immune effector cell-associated neurotoxicity syndrome (30)
Disease progression (11)
Small cell lung cancer (10)
Metastases to central nervous system (7)
Therapy partial responder (7)
Pyrexia (6)
Dysgeusia (5)
Hypotension (5)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which TARLATAMAB Alternatives Have Lower Off label use Risk?
TARLATAMAB vs TARLATAMAB-DLLE
TARLATAMAB vs TASIGNA
TARLATAMAB vs TASIMELTEON
TARLATAMAB vs TAVABOROLE
TARLATAMAB vs TAXOL